The global Ocular Drug Delivery market is projected to grow from US$ 26590 million in 2023 to US$ 35220 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period.
The US & Canada market for Ocular Drug Delivery is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Ocular Drug Delivery is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Ocular Drug Delivery is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key manufacturers of Ocular Drug Delivery include OCULAR THERAPEUTIX, INC, Alimera Sciences, Allergan, Plc, EyeGate Pharma, Valeant Pharmaceuticals International, Inc, Envisia Therapeutics, Clearside Biomedical, Graybug Vision Inc and Taiwan Liposome Company, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes:
This report presents an overview of global market for Ocular Drug Delivery, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Ocular Drug Delivery, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Ocular Drug Delivery, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Ocular Drug Delivery sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Ocular Drug Delivery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Ocular Drug Delivery sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including OCULAR THERAPEUTIX, INC, Alimera Sciences, Allergan, Plc, EyeGate Pharma, Valeant Pharmaceuticals International, Inc, Envisia Therapeutics, Clearside Biomedical, Graybug Vision Inc and Taiwan Liposome Company, etc.
By Company
OCULAR THERAPEUTIX, INC
Alimera Sciences
Allergan, Plc
EyeGate Pharma
Valeant Pharmaceuticals International, Inc
Envisia Therapeutics
Clearside Biomedical
Graybug Vision Inc
Taiwan Liposome Company
Santen Pharmaceutical
Segment by Type
Ocular Insert
Iontophoresis
Intraocular Implants
In Situ Gel & Punctal Plugs
Others
Segment by Application
Hospitals
Ambulatory Surgical Centers
Ophthalmic Clinics
Homecare Settings
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Ocular Drug Delivery in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Ocular Drug Delivery manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ocular Drug Delivery sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Ocular Drug Delivery Product Introduction
1.2 Market by Type
1.2.1 Global Ocular Drug Delivery Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Ocular Insert
1.2.3 Iontophoresis
1.2.4 Intraocular Implants
1.2.5 In Situ Gel & Punctal Plugs
1.2.6 Others
1.3 Market by Application
1.3.1 Global Ocular Drug Delivery Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Ophthalmic Clinics
1.3.5 Homecare Settings
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Ocular Drug Delivery Sales Estimates and Forecasts 2018-2029
2.2 Global Ocular Drug Delivery Revenue by Region
2.2.1 Global Ocular Drug Delivery Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Ocular Drug Delivery Revenue by Region (2018-2023)
2.2.3 Global Ocular Drug Delivery Revenue by Region (2024-2029)
2.2.4 Global Ocular Drug Delivery Revenue Market Share by Region (2018-2029)
2.3 Global Ocular Drug Delivery Sales Estimates and Forecasts 2018-2029
2.4 Global Ocular Drug Delivery Sales by Region
2.4.1 Global Ocular Drug Delivery Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Ocular Drug Delivery Sales by Region (2018-2023)
2.4.3 Global Ocular Drug Delivery Sales by Region (2024-2029)
2.4.4 Global Ocular Drug Delivery Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Ocular Drug Delivery Sales by Manufacturers
3.1.1 Global Ocular Drug Delivery Sales by Manufacturers (2018-2023)
3.1.2 Global Ocular Drug Delivery Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Ocular Drug Delivery in 2022
3.2 Global Ocular Drug Delivery Revenue by Manufacturers
3.2.1 Global Ocular Drug Delivery Revenue by Manufacturers (2018-2023)
3.2.2 Global Ocular Drug Delivery Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Ocular Drug Delivery Revenue in 2022
3.3 Global Key Players of Ocular Drug Delivery, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Ocular Drug Delivery Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Ocular Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Ocular Drug Delivery, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Ocular Drug Delivery, Product Offered and Application
3.8 Global Key Manufacturers of Ocular Drug Delivery, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Ocular Drug Delivery Sales by Type
4.1.1 Global Ocular Drug Delivery Historical Sales by Type (2018-2023)
4.1.2 Global Ocular Drug Delivery Forecasted Sales by Type (2024-2029)
4.1.3 Global Ocular Drug Delivery Sales Market Share by Type (2018-2029)
4.2 Global Ocular Drug Delivery Revenue by Type
4.2.1 Global Ocular Drug Delivery Historical Revenue by Type (2018-2023)
4.2.2 Global Ocular Drug Delivery Forecasted Revenue by Type (2024-2029)
4.2.3 Global Ocular Drug Delivery Revenue Market Share by Type (2018-2029)
4.3 Global Ocular Drug Delivery Price by Type
4.3.1 Global Ocular Drug Delivery Price by Type (2018-2023)
4.3.2 Global Ocular Drug Delivery Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Ocular Drug Delivery Sales by Application
5.1.1 Global Ocular Drug Delivery Historical Sales by Application (2018-2023)
5.1.2 Global Ocular Drug Delivery Forecasted Sales by Application (2024-2029)
5.1.3 Global Ocular Drug Delivery Sales Market Share by Application (2018-2029)
5.2 Global Ocular Drug Delivery Revenue by Application
5.2.1 Global Ocular Drug Delivery Historical Revenue by Application (2018-2023)
5.2.2 Global Ocular Drug Delivery Forecasted Revenue by Application (2024-2029)
5.2.3 Global Ocular Drug Delivery Revenue Market Share by Application (2018-2029)
5.3 Global Ocular Drug Delivery Price by Application
5.3.1 Global Ocular Drug Delivery Price by Application (2018-2023)
5.3.2 Global Ocular Drug Delivery Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Ocular Drug Delivery Market Size by Type
6.1.1 US & Canada Ocular Drug Delivery Sales by Type (2018-2029)
6.1.2 US & Canada Ocular Drug Delivery Revenue by Type (2018-2029)
6.2 US & Canada Ocular Drug Delivery Market Size by Application
6.2.1 US & Canada Ocular Drug Delivery Sales by Application (2018-2029)
6.2.2 US & Canada Ocular Drug Delivery Revenue by Application (2018-2029)
6.3 US & Canada Ocular Drug Delivery Market Size by Country
6.3.1 US & Canada Ocular Drug Delivery Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Ocular Drug Delivery Sales by Country (2018-2029)
6.3.3 US & Canada Ocular Drug Delivery Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Ocular Drug Delivery Market Size by Type
7.1.1 Europe Ocular Drug Delivery Sales by Type (2018-2029)
7.1.2 Europe Ocular Drug Delivery Revenue by Type (2018-2029)
7.2 Europe Ocular Drug Delivery Market Size by Application
7.2.1 Europe Ocular Drug Delivery Sales by Application (2018-2029)
7.2.2 Europe Ocular Drug Delivery Revenue by Application (2018-2029)
7.3 Europe Ocular Drug Delivery Market Size by Country
7.3.1 Europe Ocular Drug Delivery Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Ocular Drug Delivery Sales by Country (2018-2029)
7.3.3 Europe Ocular Drug Delivery Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Ocular Drug Delivery Market Size
8.1.1 China Ocular Drug Delivery Sales (2018-2029)
8.1.2 China Ocular Drug Delivery Revenue (2018-2029)
8.2 China Ocular Drug Delivery Market Size by Application
8.2.1 China Ocular Drug Delivery Sales by Application (2018-2029)
8.2.2 China Ocular Drug Delivery Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Ocular Drug Delivery Market Size by Type
9.1.1 Asia Ocular Drug Delivery Sales by Type (2018-2029)
9.1.2 Asia Ocular Drug Delivery Revenue by Type (2018-2029)
9.2 Asia Ocular Drug Delivery Market Size by Application
9.2.1 Asia Ocular Drug Delivery Sales by Application (2018-2029)
9.2.2 Asia Ocular Drug Delivery Revenue by Application (2018-2029)
9.3 Asia Ocular Drug Delivery Sales by Region
9.3.1 Asia Ocular Drug Delivery Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Ocular Drug Delivery Revenue by Region (2018-2029)
9.3.3 Asia Ocular Drug Delivery Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Ocular Drug Delivery Market Size by Type
10.1.1 Middle East, Africa and Latin America Ocular Drug Delivery Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Ocular Drug Delivery Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Ocular Drug Delivery Market Size by Application
10.2.1 Middle East, Africa and Latin America Ocular Drug Delivery Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Ocular Drug Delivery Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Ocular Drug Delivery Sales by Country
10.3.1 Middle East, Africa and Latin America Ocular Drug Delivery Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Ocular Drug Delivery Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Ocular Drug Delivery Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 OCULAR THERAPEUTIX, INC
11.1.1 OCULAR THERAPEUTIX, INC Company Information
11.1.2 OCULAR THERAPEUTIX, INC Overview
11.1.3 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 OCULAR THERAPEUTIX, INC Recent Developments
11.2 Alimera Sciences
11.2.1 Alimera Sciences Company Information
11.2.2 Alimera Sciences Overview
11.2.3 Alimera Sciences Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Alimera Sciences Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Alimera Sciences Recent Developments
11.3 Allergan, Plc
11.3.1 Allergan, Plc Company Information
11.3.2 Allergan, Plc Overview
11.3.3 Allergan, Plc Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Allergan, Plc Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Allergan, Plc Recent Developments
11.4 EyeGate Pharma
11.4.1 EyeGate Pharma Company Information
11.4.2 EyeGate Pharma Overview
11.4.3 EyeGate Pharma Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 EyeGate Pharma Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 EyeGate Pharma Recent Developments
11.5 Valeant Pharmaceuticals International, Inc
11.5.1 Valeant Pharmaceuticals International, Inc Company Information
11.5.2 Valeant Pharmaceuticals International, Inc Overview
11.5.3 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Valeant Pharmaceuticals International, Inc Recent Developments
11.6 Envisia Therapeutics
11.6.1 Envisia Therapeutics Company Information
11.6.2 Envisia Therapeutics Overview
11.6.3 Envisia Therapeutics Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Envisia Therapeutics Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Envisia Therapeutics Recent Developments
11.7 Clearside Biomedical
11.7.1 Clearside Biomedical Company Information
11.7.2 Clearside Biomedical Overview
11.7.3 Clearside Biomedical Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Clearside Biomedical Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Clearside Biomedical Recent Developments
11.8 Graybug Vision Inc
11.8.1 Graybug Vision Inc Company Information
11.8.2 Graybug Vision Inc Overview
11.8.3 Graybug Vision Inc Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Graybug Vision Inc Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Graybug Vision Inc Recent Developments
11.9 Taiwan Liposome Company
11.9.1 Taiwan Liposome Company Company Information
11.9.2 Taiwan Liposome Company Overview
11.9.3 Taiwan Liposome Company Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Taiwan Liposome Company Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Taiwan Liposome Company Recent Developments
11.10 Santen Pharmaceutical
11.10.1 Santen Pharmaceutical Company Information
11.10.2 Santen Pharmaceutical Overview
11.10.3 Santen Pharmaceutical Ocular Drug Delivery Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Santen Pharmaceutical Ocular Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Santen Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Ocular Drug Delivery Industry Chain Analysis
12.2 Ocular Drug Delivery Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Ocular Drug Delivery Production Mode & Process
12.4 Ocular Drug Delivery Sales and Marketing
12.4.1 Ocular Drug Delivery Sales Channels
12.4.2 Ocular Drug Delivery Distributors
12.5 Ocular Drug Delivery Customers
13 Market Dynamics
13.1 Ocular Drug Delivery Industry Trends
13.2 Ocular Drug Delivery Market Drivers
13.3 Ocular Drug Delivery Market Challenges
13.4 Ocular Drug Delivery Market Restraints
14 Key Findings in The Global Ocular Drug Delivery Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
OCULAR THERAPEUTIX, INC
Alimera Sciences
Allergan, Plc
EyeGate Pharma
Valeant Pharmaceuticals International, Inc
Envisia Therapeutics
Clearside Biomedical
Graybug Vision Inc
Taiwan Liposome Company
Santen Pharmaceutical
听
听
*If Applicable.